Selected article for: "antiviral state and hepatitis virus"
Author: Takizawa, Naoki; Yamasaki, Manabu
Title: Current landscape and future prospects of antiviral drugs derived from microbial products
  • Cord-id: 4whzcmqv
  • Document date: 2017_10_11
    • ID: 4whzcmqv
    Snippet: Viral infections are a major global health threat. Over the last 50 years, significant efforts have been devoted to the development of antiviral drugs and great success has been achieved for some viruses. However, other virus infections, such as epidemic influenza, still spread globally and new threats continue to arise from emerging and re-emerging viruses and drug-resistant viruses. In this review, the contributions of microbial products isolated in Institute of Microbial Chemistry for antivir
    Document: Viral infections are a major global health threat. Over the last 50 years, significant efforts have been devoted to the development of antiviral drugs and great success has been achieved for some viruses. However, other virus infections, such as epidemic influenza, still spread globally and new threats continue to arise from emerging and re-emerging viruses and drug-resistant viruses. In this review, the contributions of microbial products isolated in Institute of Microbial Chemistry for antiviral research are summarized. In addition, the current state of development of antiviral drugs that target influenza virus and hepatitis B virus, and the future prospects for antivirals from natural products are described and discussed.

    Search related documents:
    Co phrase search for related documents
    • active site and low density: 1
    • acute respiratory syndrome and adenovirus vector: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute respiratory syndrome and adjuvant activity: 1, 2
    • acute respiratory syndrome and liver cirrhosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and liver disease progression: 1, 2, 3, 4
    • acute respiratory syndrome and low density: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low density lipoprotein cholesterol: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • adenovirus vector and liver disease: 1
    • liver cirrhosis and low density: 1
    • liver disease and low density: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • liver disease and low density lipoprotein cholesterol: 1, 2, 3, 4, 5, 6, 7, 8